Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Observe Medical ASA ( (DE:OM50) ) just unveiled an announcement.
Observe Medical ASA has completed the subscription period for its subsequent offering of 24,000,000 new shares, each priced at NOK 0.50. The final allocation of shares is expected on 13 October 2025, with trading anticipated to commence on Euronext Expand by 22 October 2025, marking a significant step in the company’s growth strategy.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company headquartered in Oslo, Norway, focusing on developing, marketing, and selling innovative medical technology products globally. The company specializes in urine measurement and ultrasound technologies, aiming to improve patient welfare, clinical data accuracy, and health economics through its extensive product portfolio and strategic partnerships.
Average Trading Volume: 207,265
Current Market Cap: NOK51.14M
Find detailed analytics on OM50 stock on TipRanks’ Stock Analysis page.